Interview: Robin Turner, General Manager, Roche Portugal
Robin Turner, General Manager of Roche Portugal, looks back on the evolution of the affiliate, and describes how the company managed to recover its debt owed by Portuguese hospitals through…
Roche focuses on developing medicines and diagnostics that will help patients live longer, better lives. Roche strives to address unmet medical needs through excellence in science—from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
http://www.roche.com/index.htm
Estrada Nacional 249-1
2720
AMADORA
Tel: 351 – 21 425 70 00
Fax: 351 – 21 418 66 77
Robin Turner, General Manager of Roche Portugal, looks back on the evolution of the affiliate, and describes how the company managed to recover its debt owed by Portuguese hospitals through…
Sérgio Alves describes the personal and professional factors that drove his return to Portugal, where he draws on enriching experiences gained from working in various European markets. He also discusses…
Portugal boasts a well-developed universal healthcare system and saw healthcare spending increase by 6.2 percent annually between 2016 and 2021, according to the OECD. However, the representatives of innovative medicines…
Dr Maria Mota, executive director at Portugal’s Institute of Molecular Medicine (iMM), shares how the non-profit institute generated its own circular economy during the COVID-19 pandemic and saved the Portuguese…
Pedro Moura, managing director at Merck Portugal, outlines the company’s unique presence and the Portuguese affiliate’s diverse portolio. He discusses the challenges around access to innovation in Portugal, where only…
Country manager at Lundbeck Portugal, Sara Barros, came to the Danish company after a number of management positions at larger pharma companies and took on the leadership of its local…
President of the Portuguese Association Against Leukaemia (APCL), Dr Manuel Abecasis is known as the father of bone marrow transplants in Portugal. He outlines the APCL’s activities, including the organisation’s…
Speaking to PharmaBoardroom as Janseen is rebranding as Johnson & Johnson Innovative Medicine, managing director for Portugal, Filipa Mota e Costa, discusses the affiliate’s expanded local footprint and its ranking…
A doyen of Portuguese pharma, Pedro Ferraz da Costa is the long-serving president of the company started by his parents, Iberfar. In conversation with PharmaBoardroom, he discusses how Iberfar’s business…
Last year, Tecnimede Group – a family-owned titan of the Portuguese healthcare industry – appointed its first professional, non-family CEO in Antonio Donato. This marked a significant milestone in the…
Portugal’s strong legal framework along with its low production costs and strategic location within Europe have given rise to a thriving medicinal cannabis sector. With exports in 2022 that surpassed…
Erstwhile 21-year CEO of leading Portuguese generics group Tecnimede, Maria do Carmo Neves today serves as president of her country’s generics industry association, APOGEN. She outlines the highly challenging market…
Speaking from Servier’s new open-plan office in Lisbon, a space aimed at promoting cross-functional integration and “collective intelligence,” experienced industry executive Frédéric Bengold looks back on three successful years at…
See our Cookie Privacy Policy Here
